Agilent Technologies Inc A:NYSE

Last Price$86.56NYSE Closing Price as of 6:30PM ET 1/27/20

Today's Change-1.70(1.93%)
Bid (Size)$82.88 (1)
Ask (Size)$107.50 (1)
Day Low / High$86.21 - 87.17
Volume1.9 M
 

View Biotechnology IndustryPeer Comparison as of 01/27/2020

 

Agilent Technologies Inc ( NYSE )

Price: $86.56
Change: -1.70 (1.93%)
Volume: 1.9 M
6:30PM ET 1/27/2020
 
 

Alexion Pharmaceuticals Inc ( NASDAQ )

Price: $105.30
Change: +0.03 (0.03%)
Volume: 1.6 M
4:00PM ET 1/27/2020
 
 

Seattle Genetics Inc ( NASDAQ )

Price: $110.43
Change: -3.14 (2.76%)
Volume: 1.0 M
4:00PM ET 1/27/2020
 
 

Regeneron Pharmaceuticals Inc ( NASDAQ )

Price: $339.42
Change: -5.86 (1.70%)
Volume: 775.0 K
4:00PM ET 1/27/2020
 
 

Incyte Corp ( NASDAQ )

Price: $76.07
Change: -0.67 (0.87%)
Volume: 1.1 M
4:00PM ET 1/27/2020
 

Read more news Recent News

Insider Trends: 90-Days of Insider Buying at Agilent Technologies Reduced with Share Disposition
12:06PM ET 1/14/2020 MT Newswires

Michael Tang, SVP, General Counsel, and Sec., sold 5,000 shares of Agilent Technologies (A) on Jan 10, 2020, for $438,600. Subsequent to the Form 4 filing...

2021 Earnings Projection for Agilent Technologies Lowered
11:05PM ET 1/13/2020 MT Newswires

The October 31, 2021 forecasted earnings estimate for Agilent Technologies Inc (NYSE:A, Recent Price: 87.46) has been lowered. This new consensus is $3.81...

Agilent Technologies' 2021 Earnings Estimate Scaled Up
11:05PM ET 1/10/2020 MT Newswires

The 2021 forecasted earnings estimate for Agilent Technologies Inc's (NYSE:A, Recent Price: 87.59) for the year ending October 31, 2021 has been raised....

Analyst Actions: Wells Fargo Starts Agilent Technologies at Overweight With $100 Price Target
10:12AM ET 1/08/2020 MT Newswires

Agilent Technologies (A) has an average analyst rating of buy, with an average price target of $85. Price: 86.19, Change: +1.11, Percent Change: +1.30 ...

View all Commentary and Analysis

IPO Update: Beam Therapeutics Proposes IPO Terms
3:15PM ET 1/27/2020 Seeking Alpha

The Best Big Cap Stocks To Buy
2:35PM ET 1/24/2020 Seeking Alpha

Dividend Challenger Highlights: Week Of January 19
1:20PM ET 1/18/2020 Seeking Alpha

Healthcare And Biotechnology Dashboard - Update
8:20PM ET 1/15/2020 Seeking Alpha

Company Profile

Business DescriptionAgilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment comprises activity providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA. View company web site for more details
Address5301 Stevens Creek Boulevard
Santa Clara, California 95051
Phone+1.800.227.9770
Number of Employees14,800
Recent SEC Filing01/23/20208-K
President, Chief Executive Officer & DirectorMichael R. McMullen
Chief Financial Officer & Senior Vice PresidentRobert W. McMahon
Chief Technology Officer & Senior Vice PresidentDarlene J. S. Solomon
Senior Vice PresidentRichard A. Burdsall

Company Highlights

Price Open$86.54
Previous Close$88.26
52 Week Range$65.35 - 90.64
Market Capitalization$26.8 B
Shares Outstanding310.2 M
SectorHealth Technology
IndustryBiotechnology
Current Dividend / Yield$0.18 / 0.82%
Dividend Ex-Date12/30/2019
Dividend Pay-Date01/22/2020
Dividend Yield 5 Year Average0.94%
Next Earnings Announcement02/19/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings26.27
Earnings per Share$3.35
Beta vs. S&P 500N/A
Revenue$4.9 B
Net Profit Margin20.74%
Return on Equity21.79%

Analyst Ratings as of 01/06/2020

Buy
9
Overweight
1
Hold
6
Underweight
1
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset